Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: 3 | History Defined

Pauline Quirke steps away from acting following dementia diagnosis

The actress was diagnosed in 2021, her husband Steve Sheen has said.

The Independent UK

The condition that remains the UK’s leading cause of death

Northern Ireland had the highest death rate at 11.7%

The Independent UK

Dementia remains UK’s leading cause of death, analysis finds

Alzheimer’s Research UK has warned the ‘crisis will only worsen’ unless the Government takes action.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

‘I can’t tie my own shoelaces’: Alastair Stewart describes reality of living with dementia

The veteran ITN broadcaster has described how he struggles with daily tasks as he lives with dementia

The Independent UK

High fitness levels linked to reduced dementia chance among those at risk

Experts said that ‘cardiorespiratory fitness’ could be used as a predictor for thinking and memory problems in older age.

Evening Standard

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

The Independent UK

Donanemab trial patient: ‘I feel as normal as a 78-year-old can be’

Retired journalist Peter Almond took part in the clinical trial for the new Alzheimer’s drug.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

Donanemab is a so-called disease-modifying treatment.

Evening Standard

Donanemab patient: ‘The drug kept me feeling normal, but i’m scared about what happens next’

Peter Almond finished a trial for Donanemab in September having been on the drug for three years

The Independent UK

Researchers investigating if drugs can be repurposed to combat dementia

Developing new medications for diseases like Alzheimer’s can be very expensive, and take a long time.

The Independent UK

Drugs used to treat type 2 diabetes linked to lower dementia risk – study

Researchers said trials are needed to confirm their findings.

The Independent UK

‘Breakthrough’ Alzheimer's drug approved for UK use - Tech & Science Daily podcast

Listen here on your preferred podcast player.

Evening Standard

What are the symptoms and treatments for Alzheimer’s – as new drug is rejected

Lecanemab has been deamed too expensive for use on the NHS.

The Independent UK

Heart health could be biggest risk factor for future dementia rates – study

An estimated 944,000 people in the UK live with dementia.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Hundreds of thousands face being denied revolutionary new dementia drugs in England

Exclusive: Treatments near approval but lack of diagnostic capacity means NHS is unprepared for rollout, says report

The Guardian - UK

Thousands to be offered blood tests for dementia in UK trial

More than 50 clinics will offer tests to about 5,000 people who are worried about their memory in five-year trial

The Guardian - UK

Early blood test to predict dementia is step closer as biological markers identified

Scientists have found patterns of four proteins that predict onset of dementia more than a decade before formal diagnosis

The Independent UK

Hearing aid use linked to lower dementia risk, study suggests

Research was carried out in Denmark from 2003 to 2017 and included more than 500,000 people.

Get all your
news in one place.

100's of premium titles.
One news app.

Dynamite News

Addressing health, lifestyle variables might minimise the risk of young-onset dementia: Study

The findings call into question the concept that genetics is the only cause of the disease, paving the way for novel preventative techniques. Read further on Dynamite News:

Dynamite News

Addressing health, lifestyle variables might minimise the risk of young-onset dementia

A wide range of risk factors for young-onset dementia have been found by researchers. The findings call into question the concept that genetics is the only cause of the disease, paving the way for novel preventative techniques. Read Further on Dynamite News

The Independent UK

Health and lifestyle factors could increase risk of young-onset dementia – study

The findings challenge the notion that genetics are the sole cause of the condition, researchers say.

The Independent UK

The early Alzheimer’s warning signs you need to know

Experts talk through the lesser-known symptoms of the condition

The Guardian - UK

Simple blood tests for dementia to be trialled in NHS

£5m project launched with aim of having reliable tests within five years to provide quick diagnosis

The Independent UK

Blood tests for Alzheimer’s could be offered on NHS within five years – experts

Less than two-thirds of people in England with dementia have a formal diagnosis.

The Guardian - UK

Dementia could affect 1.7m people in England and Wales by 2040, data finds

Figure is 42% higher than previous estimates and would pose ‘enormous threat’ to healthcare systems

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

the University of Exeter

119 stories

the University of Manchester

117 stories

the Alzheimer Society

59 stories

the National Institute for Health and Care Excellence

30 stories

PQA

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.